Orange Book product · Generic (ANDA)
SUMATRIPTAN
SUMATRIPTAN
Generic (ANDA)ANDA 213465TE ABRX PADAGIS ISRAEL
At a glance
Sep 21, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 21, 2020
5 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
SUMATRIPTAN
Strength
5MG/SPRAY
Dosage form
SPRAY
Route
NASAL
TE code
AB
Application
ANDA 213465
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SUMATRIPTAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
